Health and Fitness
Health and Fitness
Wed, May 19, 2010
[ 05:30 AM ] - Market Wire
[ 05:30 AM ] - Market Wire
[ 04:30 AM ] - Market Wire
[ 04:08 AM ] - Market Wire
[ 04:05 AM ] - Market Wire
[ 03:05 AM ] - Market Wire
[ 02:39 AM ] - Market Wire
[ 02:30 AM ] - Market Wire
[ 01:18 AM ] - Market Wire
Tue, May 18, 2010
[ 10:00 PM ] - Market Wire
[ 06:00 PM ] - Market Wire
[ 03:16 PM ] - Market Wire
[ 02:05 PM ] - Market Wire
[ 01:20 PM ] - Market Wire
[ 01:18 PM ] - Market Wire
[ 01:15 PM ] - Market Wire
[ 01:05 PM ] - Market Wire
[ 01:00 PM ] - Market Wire
[ 11:09 AM ] - Market Wire
[ 11:00 AM ] - Market Wire
[ 10:26 AM ] - Market Wire
Oncolytics Biotech(R) Inc. Announces Publication of Phase I Clinical Trial Results in Clinical Cancer Research
- The ICR is Europe's leading cancer research centre - The ICR has been ranked the UK's top academic research centre, based on the results of the Higher Education Funding Council's Research Assessment Exercise - The ICR works closely with partner The Royal Marsden NHS Foundation Trust to ensure patients immediately benefit from new research. Together the two organisations form the largest comprehensive cancer centre in Europe - The ICR has charitable status and relies on voluntary income, spending 95 pence in every pound of total income directly on research - As a college of the University of London, the ICR also provides postgraduate higher education of international distinction - Over its 100-year history, the ICR's achievements include identifying the potential link between smoking and lung cancer which was subsequently confirmed, discovering that DNA damage is the basic cause of cancer and isolating more cancer-related genes than any other organisation in the world
Contributing Sources